1. P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT. (23rd June 2022) Authors: Borchmann, P.; Lohneis, A.; Gödel, P.; Balke-Want, H.; Schmid, C.; Ayuk, F.; Holtkamp, S.; Hanssens, L.; Zadoyan, G.; Friedrichs, B.; Assenmacher, M.; Bürger, I.; Schneider, D.; Overstijns, T.; Scheid, C.; Holtick, U.; Miltenyi, S.; Hallek, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1070 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1024: IMPACT OF TP53 IN MYELOFIBROSIS UNDERGOING STEM CELL TRANSPLANTATION. (23rd June 2022) Authors: Gagelmann, N.; Badbaran, A.; Panagiota, V.; Wolschke, C.; Ayuk, F.; Thol, F.; Ditschkowski, M.; Cassinat, B.; Robin, M.; Schroeder, T.; Heuser, M.; Reinhardt, H. C.; Kröger, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL): A GLA/DRST STUDY. (23rd June 2022) Authors: Derigs, P.; Bethge, W.; Holtick, U.; von Tresckow, B.; Ayuk, F.; Penack, O.; Vucinic, V.; von Bonin, M.; Baldus, C.; Mougiakakos, D.; Wulf, G.; Schnetzke, U.; Stelljes, M.; Thomas, S.; Schroers, R.; Kroeger, N.; Dreger, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗